Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer.
Pharmacoeconomics
; 39(8): 953-964, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-34089503
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Circulating Tumor DNA
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Health_economic_evaluation
/
Observational_studies
Aspects:
Patient_preference
Limits:
Humans
Country/Region as subject:
Oceania
Language:
En
Journal:
Pharmacoeconomics
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2021
Document type:
Article
Affiliation country:
Australia
Country of publication:
New Zealand